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CC BY-NC-ND license (http://creativeAbstract Objective: Atherosclerosis is the fundamental pathophysiologic component of car-
diovascular disease, and Tiaozhi Tongmai Granules show great efficiency in the treatment of
the disease. However, the mechanism of Tiaozhi Tongmai Granules is still unclear. In this
study, we have combined experiments with network pharmacology to explore the anti-
atherosclerosis mechanism of Tiaozhi Tongmai Granules.
Method: 120 male ApoE/ mice were randomly divided into three groups: the model group,
Chinese herb group and Atorvastatin group. The model group, Atorvastatin group and Chinese
herb group were fed with a high-fat diet, a high-fat diet plus atorvastatin (5.1 mg/kg/d) and a
high-fat diet plus Tiaozhi Tongmai Granules (16.5 g/kg/d) for 16 weeks, respectively. Athero-
genesis was identified by H&E staining. The colocalization of neutral lipid stain BODIPY and
microtubule-associated protein 1 light chain 3 (LC3) and the colocalization of BODIPY and
lysosomal-associated membrane protein 1 (LAMP1) within ApoE/ mice aortic plaques were
tested using fluorescence confocal microscopy and the Pearson’s coefficients were calculated.
To further explore the anti-atherosclerosis mechanism of Tiaozhi Tongmai Granules, the
network pharmacology was used to construct the herb-compound-target network.
Results: The size of the aortic lipid plaque in the Chinese herb group and Atorvastatin group
were smaller compared with the model group on the 16th week. Compared with the model
group on the 16th week, the BODIPY and LC3 colocalization rate, the BODIPY and LAMP1 colo-
calization rate of the Chinese herb group and Atorvastatin group all presented significant(S. Guo).
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Autophagosome activity in macrophage for atherosclerotic plaques 195increase in the aortic plaque (P < .001), showing that Tiaozhi Tongmai Granules could enhance
autophagosome activity in the macrophage. In the herb-compound-target network, 17 active
compounds and 27 targets were obtained through literature searching and using LHRI & DAVID
Bioinformatics. It was found that 23 targets were correlated with the macrophage. Some of
them participated in macrophage inflammatory response, and the other targets could pro-
mote/inhibit phagocytosis of the macrophage. It was hypothesized that the active compounds
of Tiaozhi Tongmai Granules were acting on these targets and having y the biological effects.
Conclusions: In the progression stage of atherosclerosis, Tiaozhi Tongmai Granules can still make
the macrophage have higher autophagosome activity, and play a role of anti-atherogenesis.
ª 2015 Beijing University of Chinese Medicine. Production and hosting by Elsevier B.V. This is an
open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-
nc-nd/4.0/).Introduction
With the deepening study of atherosclerosis (AS), there has
been an increasing number of reports on the function of
lipid autophagy in the macrophage. Autophagy, the main
metabolic pathway of cell decomposition, is the process of
cell delivery of cytoplasmic components to lysosomes for
degradation.1 Autophagy can maintain a low basal level in
cells, and the level will rapidly up-regulate when cells need
adequate nutrition and energy supply.2 It has been demon-
strated that the autophagy lysosomal system can directly
transport lipid to lysosomes for degradation.3,4 The insuffi-
cient degradation and clearance of macrophage cholesterol
is caused by the decreased autophagy function, then a large
number of lipid droplets accumulate. Increased lipid drop-
lets accelerate the generation of foam cells, leading to the
formation of atherosclerotic plaques eventually.5
Mevalonate lactone derivatives, which is called ator-
vastatin for short, is the first listing of statins and the most
commonly used drug to regulate lipid and play a key role
against atherosclerosis.6,7 Recent studies have confirmed
atorvastatin can promote the expression of protective
autophagy through AMPK pathways.8,9 Although atorvasta-
tin is a kind of lipid-lowering drug which promotes auto-
phagy, its mechanism in autophagy regulation has not been
elucidated. Long-term use of atorvastatin would cause liver
toxicity and myalgia, and some patients are still suffering
from plaque progression. So atorvastatin may not be an
ideal drug.
Different from Western medicine which concentrates on
a specific pathogenic process, traditional Chinese medicine
(TCM) has been acknowledged as a popular complementary
and alternative medicine in the world. Several Chinese
herbs have already been transformed into commercial
products fin the treatment of AS, such as Xuezhikang
Capsule,10 and Zhibituo Capsule.11 Although a lot of clin-
ical trials and basic experimental studies have demon-
strated the effectiveness of Chinese herbal products,
Chinese medicine still has a predicament in the past de-
cades. Single herb has an intricate composition and more
than one active ingredient, not to mention the formula,
which hinders deep research on Chinese medicine. Nowa-
days, the emergence of system pharmacology provides
another new perspective for the study of complex Chinese
medicine system, for example, the network pharmacology,offers holistic approaches to study the effect of herbal
formula.12
Tiaozhi Tongmai Granules is based on the classical pre-
scriptiondAngelicae Sinensis decoction for supplementing
blood (Chinese namedDanggui Buxue Tang) which is
comprised of seven herbs capable of treating AS. Our pre-
vious study demonstrates that the herbs in Tiaozhi Tongmai
Granules produce an anti-atherogenic effect via the hepa-
tocyte ABCA1/macrophage ABCA1 pathway and reduce the
level of pro-inflammatory cytokines.13 In this study, we
have employed ApoE/ mice to explore the functional role
of Tiaozhi Tongmai Granules in autophagy during athero-
sclerosis, then the system pharmacology technique has
been used to further unveil the mechanism of Tiaozhi
Tongmai Granules in the treatment of atherosclerosis.
Materials and methods
Animals and diets
A total of 120 healthy male ApoE/ mice aged 9e10 weeks
with an initial weight of 20 g approximately were purchased
from the Beijing HFK Bioscience (Beijing, China) [permit
number SCXK(Beijing)2009-0008]. High-fat diet composed
of cholesterol 1%, lard 3%, yolk powder 10% and normal diet
86% were obtained from the Beijing HFK Bioscience (Bei-
jing, China). The present study was conducted strictly ac-
cording to the recommendations set forth in the Chinese
Guide for the Care and Use of Laboratory Animals. The
Committee on the Ethics of Animal Experiments of the
Beijing University of Chinese Medicine approved this study
(approval number: 37570).
Drugs
Tiaozhi Tongmai Granules, based on a TCM empirical for-
mula, is comprised of seven ingredients: Milkvetch Root
(Astragalus membrananceus (Fisch.) 20 g, Chinese Angelia
[Angelica sinensis (Oliv.) Diels] 15 g, Cassia Seed (Ssiadi-
capsuiaris L.) 30 g, Oriental Waterplantain Rhizome [Alisma
orientale (Samuels) Juzep.] 12 g, Hawthorn Fruit (Cratae-
gus maximowiczii C. K. Schneid ) 30 g, Earhtwarm (C.
maximowiczii C. K. Schneid ) 15 g, and Sanchi [Panax
pseudoginseng Wall. var. notoginseng (Burkill ) Hoo et
196 C. Zheng et al.(Tseng) 6 g]. The herbal granule compound was prepared
according to standard procedure.14 The seven herbs were
decocted together twice in water, and the decoction was
filtered. The filtrate was collected and concentrated into
an appropriate amount and spray-dried. Adjunct in-
gredients were added and blended evenly. The granules
were prepared with each dose ultimately weighing 20 g,
which was purchased from the Third Affiliated Hospital to
the Beijing University of Chinese Medicine. Atorvastatin
calcium tablets (Pfizer Pharmaceuticals, Approval No.
H20051408, Batch No. 1237304) was provided by the Chi-
naeJapan Friendship Hospital.
Quality control of Tiaozhi Tongmai Granules
The chief herb or the leading ingredient in Tiaozhi Tong-
mai Granules is astragaloside IV which acts as one of the
main bioactive components, and thus is the marker of
quality control for the herb.15,16 The content of astraga-
loside IV was detected using previously reported
method.17,18 In the prepared granules, astragaloside IV
took up 0.046%, which met the requirements (0.040%) of
the Pharmacopoeia of People’s Republic of China, 2010
Edition.19 In addition, a component identification test for
another main ingredient in the granules, Cassia Seed, was
performed according to a previously described method and
confirmed that the herb contained chrysophanol and aur-
antio-obtusin.20 The two representative markers of Cassia
Seed are prescribed by the Pharmacopoeia. The afore-
mentioned components are described in detail in supple-
mental files (Fig. S1, S2). All herbs were reliably provided
by the Beijing University of Chinese Medicine Third Affili-
ated Hospital.
Animal groups
Animal normal diet was given for 1 week, and all ApoE/
mice were randomly divided into 3 groups (40 in each
group). The model group received high-fat diet for 16
weeks before sacrifice. The Atorvastatin group received
high-fat diet plus atorvastatin for 16 weeks before sacrifice.
The Chinese herb group received high-fat diet plus Tiaozhi
Tongmai Granules for 16 weeks before sacrifice.
Drug intervention
Atorvastatin clinical equivalent dose was about 5.1 mg/
kg/d (equivalent to 40 mg per 70 kg adult per day), and
the clinical equivalent dose of Tiaozhi Tongmai Granules
was about 16.5 g (crude drug)/kg/d (equivalent to 128 g
(crude drug) per 70 kg adult per day) all given via intra-
gastric injection. The two drugs were dissolved in an
appropriate amount of distilled water to ensure the drug
delivery volume was maintained at 5 mL per mouse. The
model group was intragastrically administered with the
same volume of distilled water alone without any drugs.
Five mice were kept in one cage, and raised in the SPF
Animal Laboratory of the Beijing University of Chinese
Medicine. They were given adlibitum access to distilled
water and high-fat diet.Specimen collection
The mice were fasted for 36 hours before sampling. That is
in a nonspecific manner to activate the level of autophagy
in vivo by the way of hunger.21 After sacrificed by overdose
of chloral hydrate, the aorta tissue was cut, a part of the
aorta was fixed in 10% neutral buffered formalin and
embedded in paraffin, waiting for slice and H&E staining.
The other part sealed with aluminum foil, was placed in a
Frozen Section Machine. The frozen sections were observed
by immunofluorescence staining.
Morphological analysis
Sections were stained with Harris hematoxylin and eosin
(H&E) using Leica ST 5020 Multistainer (Germany). Images
were viewed and captured with an Olympus BX53 micro-
scope attached to the Olympus CellSens imaging software
platform (Japan). This staining method and other staining
methods were basically the same.
Immunofluorescence staining and confocal laser
technology
Cells were observed through a laser scanning confocal mi-
croscope (Olympus, Japan). Rabbit anti-mouse LC3B IgG
antibody (L7543, Sigma) and goat anti-rabbit IgG antibody
(ab150079, Abcam) were used for the staining of autopha-
gosomes. Rabbit anti-mouse LAMP1 IgG antibody (ab24170,
Abcam) and goat anti-rabbit IgG antibody (ab150079,
Abcam) were used for the staining of lysosomes. The
staining method was similar to other staining methods.
Autophagosomes and lipid droplets were labeled with
anti-LC3B antibody and BODIPY, and anti-LAMP1 antibody
and BODIPY were labeled with lysosomes and lipid droplets.
Each experimental group’s colocalization ratio of LC3B
protein and BODIPY, LAMP1 protein and BODIPY was then
calculated. And the colocalization of autophagosomes and
lipid droplets, lysosomes and lipid droplets were observed
with a confocal laser microscope. The two things did not
colocalized if the colocalization coefficient was smaller
than 0.2. If the colocalization coefficient was larger than
0.3, colocalization formed.
Statistical analysis
SPSS (version 18.0) was used for statistical analysis. All data
were presented as mean (SD). One-way analysis of variance
(ANOVA) was applied to comparing the mean value of single
variable measurement data. LSD or S-N-K method was used
for multiple comparisons. Game Howell analysis was used if
there was heterogeneity in variance. Enumeration data
were treated with the chi-square test. P-values less than
0.05 were considered significant.
Building herb-compound-target network
All chemical compounds from these 7 herbs were collected
from the TCMSP database (http://lsp.nwsuaf.edu.cn/
tcmsp.php). Compound molecules screening according to
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database. With the previously developed model from pre-
decessors,22 the compounds with oral bioavailability (OB)
30% and drug-likeness index (DL) 0.18 as the active
molecules were chosen.23 Meanwhile, the target prediction
was performed for the candidate compounds based on the
Random Forest (RF) and Support Vector Machine (SVM).
Then the herb-compound-target network was built by
Cytoscape using the network node of both Degree and
Betweenness greater than the mean value as the hub node
to do Topology analysis.Figure 1 The H&E staining of ApoE/ mice paraffin sections of
vastatin group; C and F for the Chinese herb group. (2) The part of
C): bars Z 100 mm; (D, E, F)bars Z 50 mm.Results
The formation of aortic plaque and drug
intervention
On the 16th week, the successful rate of the model was
90%. H&E staining results showed that the ApoE/ mice
aorta had formed a clear plaque, and lipid core could be
found. A large volume of lipid plaque was seen in the model
group, and lipid plaque occupied most of the lumen. Inaorta. (1) A and D for the model group; B and E for the ator-
dotted line circle in D, E, F is atherosclerotic plaque. (3) (A, B,
Figure 2 Staining of neutral lipids in the frozen sections of aorta (Bars Z 10 mm).
Figure 3 Immunofluorescence staining of the frozen sections of aortic LC3B (Bars Z 10 mm).
198 C. Zheng et al.
Figure 4 LC3B and BODIPY confocal laser (Bars Z 10 mm).
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tatin group and Chinese herb group was seen. Some of their
vascular elastic fibers still maintained corrugated contin-
uous arrangement (Fig. 1AeF).
Lipid droplets distribution and autophagosomes
activity of macrophages in atherosclerotic plaques
On the 16th week, in the ApoE/ mice aortic plaque tis-
sues, there was uneven wilder distribution of lipid droplets
in the shallow and middle of the plaques, while lipid
droplets in the deep of the plaques had less distribution.
The model group had a large number of lipid droplets in
disperse distribution. The atorvastatin group and Chinese
herb group had less lipid droplets, and most of them
distributed in the shallow layer of the plaques (Fig. 2). On
the 16th week, the model group’s aortic plaque LC3B pro-
tein expressed a low level. Compared with the model
group, the atorvastatin and Chinese herb groups’ aortic
plaque LC3B protein expressed a higher level. Autophago-
somes was uniformly distributed in plaques (Fig. 3).
The interaction of autophagosomes and lipid
plaques
The results showed that, on the week 16, lipid droplets and
LC3B protein of the model group had no significant coloc-
alization. Lipid droplets still showed a larger dot shape. In
contrast, lipid droplets and LC3B protein of the atorvastatin
group and Chinese herb group showed a significantcolocalization. The number of lipid droplets was not that
much and had a small volume. The majority of lipid drop-
lets was dispersed in fine particles (Fig. 4).
The data displayed that the colocalization coefficient of
the model group was less than 0.2. Compared with the
model group, the colocalization coefficient of the ator-
vastatin group and Chinese herb group was increased
significantly (F Z 128.430, P < .001) to over 0.3. Compar-
ison between the two drug groups, the colocalization co-
efficient of the atorvastatin group was higher than that in
the Chinese herb group, but there was no significant sta-
tistical difference (P Z .060). (Fig. 5).
The interaction of lysosomes and lipid plaques
The results showed that each experimental group’s plaque
macrophage LAMP1 protein expression level was nearly the
same. However, LAMP1 protein and BODIPY of the model
group did not have significant colocalization. In contrast,
LAMP1 protein and BODIPY of the atorvastatin group and
Chinese herb group had a higher colocalization (Fig. 6).
By the calculation of colocalization ratio of LAMP1
protein and BODIPY, it was found that the colocalization
coefficient of the model group was less than 0.2.
Compared with the model group, the colocalization co-
efficient of the atorvastatin group and Chinese herb group
was increased significantly (F Z 174.697, P < .001), more
than 0.3. The colocalization coefficient of the atorvastatin
group was higher than that in the Chinese herb group, but
there was no statistically significant difference
(P Z .070). (Fig. 7).
Figure 5 LC3B and BODIPY of the aortic plaque colocalization rate. A, B, C: The colocalization ratio chart: the greater the black
dot coverage area is, the higher the degree of colocalization is. D: Pearson colocalization coefficients of each group. *P < .001,
compared with the model group.
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The corresponding compounds of the 7 herbs and targets
information are shown in Table 1. Among them, Milkvetch
Root retains most of the compounds, including 25 active
compounds and 221 targets. In the herb-compound-target
network we have obtained 47 hub nodes, containing 17
active compounds and 27 targets. Through literature
searching and using LHRI & DAVID Bioinformatics, we have
found that 23 targets were correlated with the macro-
phage. Those 23 targets are roughly divided into 3 cate-
gories, some of them such as Nitric-oxide synthase (NOS),
Cyclin A2, and Sodium channel protein presented in the
macrophage. Some of the targets participate in macro-
phage inflammatory response, including Androgen receptor
(AR), Prostaglandin G/H synthase 2 (PTGS2), Prostaglandin
G/H synthase 1 (PTGS1), Dipeptidyl peptidase IV (DPP4),
Thrombin, Trypsin-1, Proto-oncogene serine/threonine-
protein kinase Pim-1 (PIM1), Heat shock protein 90
(HSP90), Glucocorticoid receptor (GR), mRNA of PKA Cata-
lytic Subunit C-alpha (PKA-a) and Acetylcholinesterase
(AchE). Some targets could promote or inhibit phagocytosis
of the macrophage, including Estrogen receptor (ER),Glycogen synthase kinase-3 beta (GSK-3b) and DNA topo-
isomerase II (TOPO II). In these 23 targets, Mitogen-
activated protein kinase 14 (MAPK14) and Peroxisome pro-
liferator activated receptor gamma (PPAR-g) were closely
related to the macrophage. Furthermore, we did not find
correlation between the macrophage and Carbonic anhy-
drase II(CAII), Cell division protein kinase 2 (CDK2), mRNA
of Protein-tyrosine phosphatase, non-receptor type
1(PTPases), Serine/threonine-protein kinase Chk1(CHEK1)
(Fig. 8).
Discussion
In the present study, the results showed that with the
progression of atherosclerotic lesions, the level of auto-
phagy in ApoE/ mice aortic tissue was decreased. This
results proved that when cells were exposed to lipid stim-
ulation, autophagy levels could be activated and up-
regulated. However, when cells loaded with a large num-
ber of lipids, the level of autophagy and the degradation
ability of autophagy lysosomal system were decreased.
Similar as atorvastatin, Tiaozhi Tongmai Granules were
able to improve the function of autophagy in lipids.
Figure 6 LAMP1 and BODIPY confocal laser (Bars Z 10 mm).
Figure 7 LAMP1 and BODIPY of the aortic plaque colocalization rate. A, B, C: The colocalization ratio chart, black dot coverage
area is greater, the higher the degree of colocalization. D: Pearson colocalization coefficients of each group. *P < .001, compared
with the model group.
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Table 1 Herbal compounds and target number.
Herb name Compounds active
compounds
Targets
Milkvetch Root 87 25 221
Chinese Angelia 125 6 76
Cassia Seed 68 20 78
Oriental
Waterplantain
Rhizome
46 11 33
Hawthorn Fruit 26 5 32
Earhtwarm 23 2 40
Sanchi 119 11 203
Figure 8 Herb-compo
202 C. Zheng et al.Meanwhile, H&E staining results showed the Chinese herb
group had a smaller volume of lipid plaque, which also
explained the direct relation between autophagy and
degradation of lipid droplets.
In TCM theory, the spleen is in charge of transformation
and transportation of essence of water and grain, providing
the acquired essence for the body, which is also the source
of qi and blood. That is to say, the normal transport func-
tion of the spleen provides sufficient qi and blood. At the
subcellular level, the autophagy lysosomal system, which
includes the process of transporting intracellular damaged
or denatured proteins and lipids to lysosomal degrada-
tion.24 This process is similar to the transport function of
the spleen. Intracellular lipid metabolism will be blocked to
a certain extent if the cell autophagy capacity is declined.und-target network.
Autophagosome activity in macrophage for atherosclerotic plaques 203Hindered metabolism contributes to increase volume of
lipid droplets, and the quantity also increases. If the lipid
droplets exceed the limit beyond tolerance of the cells, the
microscopic particles of phlegm will form on the cell. If the
cells with particles of phlegm aggregate too much, it will
lead to the formation of fatty streaks.25 On the macro-
scopic view of the vessel wall tissues, it has already formed
a lipid plaque with phlegm. The chief herb in Tiaozhi
Tongmai Granules is Milkvetch Root, which is commonly
used in TCM to reinforce qi and ascend yang. Chinese
Angelia, another herb in Tiaozhi Tongmai Granules, is one
of the most important medicine to activate blood circula-
tion. Qi is the commander of blood and blood is the mother
of qi. Qi and blood mutually transform. On the other hand,
the TCM classic, Bian Zheng Qi Wen (Fantastic Story of
Syndrome Differentiation) says excessive phlegm contrib-
utes to qi block; normal qi movement promotes phlegm
resolving. An adequate amount of qi and blood may guar-
antee the function of the spleen. Other herbs in Tiaozhi
Tongmai Granules include Cassia Seed, Oriental Water-
plantain Rhizome, Hawthorn Fruit, Sanchi, and Earhtwarm.
They work together to improve the function of replenishing
qi, activating blood, strengthening the spleen, and
resolving phlegm.
In the herb-compound-target network, our data provide
a mechanism explaining the link between Tiaozhi Tongmai
Granules and autophagy in the macrophage. In these 23
targets, MAPK14 and PPAR-g are closely related to the
macrophage. PPAR-g in the macrophage is linked to
improved macrophage M2 phenotype polarization, exerting
their ability to inhibit expression of many inflammatory
mediators.26 Agonists of PPAR-g can stimulate cholesterol
efflux via up-regulating the expression of ABCA1.27 MAPK14
is an immune modulating signal, which can regulate host
response and resist pathogen invasion, stimulate macro-
phage producing NO, TNF-a and so forth.28 Another part of
targets participates in inflammatory responses. AR and GR
from the same family, act as a coordinating hub in anti-
inflammatory responses. GR maintained stable due to the
function of HSP90. HSP90 is a kind of functionally related
proteins, which has a broad interaction with many pro-
inflammatory kinase cascades.29 Recent studies show that
HSP90 is responsible for the folding and stabilization of
PIM1, which is another target participating in inflammatory
response.30 DPP4 is expressed in inflammatory cells
including macrophages, and DPP4 inhibitor exerts anti-
atherosclerotic effects and reduces inflammation via inhi-
bition of monocyte activation/chemotaxis.31 PTGS1 and
PTGS2 are responsible for the production of NO and pros-
taglandin E2 (PGE2), two important inflammatory media-
tors.32 PKA-a through PKA-and PKC-dependent pathways
down-regulate the expression level of inflammatory fac-
tors.33 In addition, we have also found the relationship
between some targets and phagocytosis of the macro-
phage. Many studies show that after 50 years old, the risk of
atherosclerosis in women is gradually increased because of
the estrogen level is decreased. However ER promotes
phagocytosis of macrophages, especially ox-LDL.34 GSK-3b
is responsible for reduced expression of ABCA1 and SR-B1,
ABCA1 facilitates cholesterol export and generation of
HDL while SR-B1 promotes bidirectional cholesterol ex-
change.33 ABCA1 promoter activity can increase byEtoposide, which is an inhibitor of DNA TOPO II.35 Conse-
quently, we have speculated that the active compounds of
Tiaozhi Tongmai Granules are acting on these targets and
have the biological effects.
Conclusion
In this work, our results show that Tiaozhi Tongmai Gran-
ules could effectively promote autophagosome activity in
the macrophage in the treatment of atherosclerosis, and
the herb-compound-target network indicates the active
compounds of Tiaozhi Tongmai Granules effecting on 23
potential targets. It is worth to note that these targets
could be new breakthrough points of research. Despite
these potentially interesting associations, further experi-
mental testing of these hypotheses is necessary.
Competing interests
The authors declare that they have no competing interests.
Funding
This work was support by the International S&T Cooperation
Program of China (No. 2011DFA33040).
Author’s contributions
SWG conceived the study, QS designed the study. LZ wrote
the manuscript. All authors read and approved the final
manuscript.
Abbreviations
ABCA1 ATP-binding cassette transporter A1
AMPK AMP activated protein kinase
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